Patents by Inventor Ryosuke Ueki

Ryosuke Ueki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240277853
    Abstract: Provided is a medium-molecular-weight compound conjugate capable of improving pharmacokinetic profile of a medium-molecular-weight compound, that is easy to obtain, safer to a biological body, and useful in vivo such as a nucleic acid aptamer, and a method of producing the same. The PMPC-medium-molecular-weight compound conjugate of the present invention is obtained by conjugating PMPC (poly-2-(methacryloyloxy)ethyl phosphoryicholine) to a medium-molecular-weight compound.
    Type: Application
    Filed: June 3, 2022
    Publication date: August 22, 2024
    Applicants: TAGCYX Biotechnologies Inc., The University of Tokyo
    Inventors: Susumu MUTO, Shinsuke SANDO, Miyuki HORI, Haishun PIAO, Kensuke OWARI, Kazunobu FUTAMI, Ryosuke UEKI, Yutaro SAITO, Seojung CHO
  • Patent number: 10619161
    Abstract: Provided is an aptamer including a polynucleotide of any of the following (a) to (c) and capable of binding to an HGF receptor to exhibit an activity of inhibiting the binding of HGF to the HGF receptor. (a) A polynucleotide consisting of a base sequence set forth in SEQ ID NO:1, (b) A polynucleotide consisting of a base sequence having the deletion, substitution, insertion and/or addition of one to several bases in the base sequence set forth in SEQ ID NO:1, and (c) A polynucleotide consisting of a base sequence having a sequence identity of 80% or more to the base sequence set forth in SEQ ID NO:1.
    Type: Grant
    Filed: September 9, 2015
    Date of Patent: April 14, 2020
    Assignee: THE UNIVERSITY OF TOKYO
    Inventors: Shinsuke Sando, Ryosuke Ueki
  • Publication number: 20170275630
    Abstract: Provided is an aptamer including a polynucleotide of any of the following (a) to (c) and capable of binding to an HGF receptor to exhibit an activity of inhibiting the binding of HGF to the HGF receptor. (a) A polynucleotide consisting of a base sequence set forth in SEQ ID NO: 1, (b) A polynucleotide consisting of a base sequence having the deletion, substitution, insertion and/or addition of one to several bases in the base sequence set forth in SEQ ID NO: 1, and (c) A polynucleotide consisting of a base sequence having a sequence identity of 80% or more to the base sequence set forth in SEQ ID NO: 1.
    Type: Application
    Filed: September 9, 2015
    Publication date: September 28, 2017
    Applicant: The University of Tokyo
    Inventors: Shinsuke Sando, Ryosuke Ueki